Do Investors Need to Remain Patient?

Does the selloff in 1H22 represent a buying opportunity for the remainder of 2022 or do investors need to remain patient? Equity Armor Investments Chief Investment Officer Brian Stutland joins Jill Malandrino on Nasdaq TradeTalks to discuss.